Professor of Pathology and Genomic Medicine, Academic Institute
Full Member, Research Institute
Weill Cornell Medical College
After completing her postdoctoral training, Dr. Mody joined the faculty at the Baylor College of Medicine in Houston, Texas as an Instructor of Pathology in 1984. She received her full professorship there in 2000, and held the Ibrahim Ramzy Endowed Chair. In 2007-2008, Dr. Mody served as President of the American Society of Cytopathology (ASC). She has given numerous workshops, teleconferences, symposia and lectures at its national meetings. She has also served on the ASC Executive Board, Chaired the Scientific Program Committee and chaired the Quality Assurance Committee. She co-chaired the Practice Guidelines Committee, which developed the Cervical Cytology Practice Guidelines for which she received the President’s Award of the ASC in 1999. In 2002, she received the Lansky Award of the College of American Pathologists (CAP) for her leadership role in cytology, and has served as Chair of the CAP Cytopathology Resource Committee. From 2004-08, Dr. Mody was appointed to the Clinical Laboratory Improvement Advisory Committee (CLIAC) of the CDC, where she served as an advisor on cytology issues to the CDC and CMS. Previous leadership positions include President of the Texas Society of Cytology, and Chair of Scientific Program of the Houston Society of Clinical Pathologists. In 2014 she published an 800+ page text book: Diagnostic Pathology Cytopathology. She is currently the Editor-in-Chief of The Journal of the American Society of Cytopathology.
Dr. Mody’s previous research interests have been in the area of glandular lesions in cervicovaginal cytology and pathology, as well as bone and soft tissue cytology and pathology. Her early papers on tissue and bone reactions to implants were instrumental to the defense when reactions to breast implants were the subject of major litigation in the United States. Dr. Mody’s current research focuses on the application of HPV testing and genotyping in low- and high-risk populations, application of new imaging modalities to diagnostic cytopathology, and immunohistochemical and molecular testing in cytology.